Ruggaard & Associates’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.4K Hold
10,000
0.01% 127
2026
Q1
$29.2K Hold
10,000
0.01% 122
2025
Q4
$24.7K Hold
10,000
0.01% 120
2025
Q3
$22.3K Hold
10,000
0.01% 120
2025
Q2
$24.1K Hold
10,000
0.01% 116
2025
Q1
$23.3K Hold
10,000
0.01% 115
2024
Q4
$18.5K Hold
10,000
0.01% 110
2024
Q3
$24.4K Hold
10,000
0.01% 116
2024
Q2
$20.5K Hold
10,000
0.01% 116
2024
Q1
$24.8K Hold
10,000
0.01% 115
2023
Q4
$28K Hold
10,000
0.01% 115
2023
Q3
$25.8K Hold
10,000
0.02% 106
2023
Q2
$31.8K Hold
10,000
0.02% 108
2023
Q1
$28.2K Buy
+10,000
New +$26.2K 0.02% 105

Other funds holding ABEV

Ruggaard & Associates's ABEV Position: Q2 2026 in Review

Ruggaard & Associates held its Ambev (ABEV) position steady in Q2 2026 at 10,000 shares worth $31.4K. The position accounts for 0.01% of the portfolio, ranked #127.

Ruggaard & Associates first reported a position in ABEV in Q1 2023 and has held it in 14 quarters since. The position peaked at $31.8K in Q2 2023. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Ruggaard & Associates held 10,000 shares of Ambev worth $31.4K as of Q2 2026.
  • Ruggaard & Associates left its Ambev share count unchanged in Q2 2026.
  • Ambev made up 0.01% of Ruggaard & Associates's portfolio in Q2 2026, its #127 holding.
  • Ruggaard & Associates first reported a position in Ambev in Q1 2023 and has held it in 14 quarters since.
  • Ruggaard & Associates's Ambev position peaked at $31.8K in Q2 2023.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Ruggaard & Associates's 13F filing for Q2 2026, filed 17 Aug 2026.